INSIGHTS ON MANUFACTURING LOGISTICS
-
How The Tariffs Could Impact Your Drug Development Supply Chain
Explore how a fully integrated, U.S.-based supply chain strategy can help you navigate potential tariff risks, reduce complexity, and strengthen resilience in pharmaceutical development.
-
Forget About Isolators: Switching From Manual Vial To Automated Bag Filling
Discover how transitioning from manual vial filling to single-use bag systems can reduce contamination risk, improve accuracy, and enhance GMP compliance in biopharmaceutical manufacturing.
-
Friendshoring: A Strategic Shift In Pharma Supply Chains
To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models and seeking more resilient, forward-looking strategies.
-
Integration Of Container Closure Integrity In Contract Manufacturing
Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.
-
Managing Risks In Injectable Drug Delivery3/13/2025
Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.
-
Small Volume ATMP Cryo-Freezing Strategies3/11/2025
Discover best practices for cryopreserving small-volume ATMPs, focusing on sterility, viability, and efficiency with advanced containers and packaging.
-
Human Factors Testing: Engaging End-Users In Med Device Development3/11/2025
Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.
-
ATMP Cryopreservation Done Right - Best Practice In Small Volume Cryo-Freezing3/11/2025
Explore best practices for cryopreserving small-volume advanced therapy medicinal products (ATMPs), emphasizing sterility, cell viability, and efficiency using innovative single-use systems and aseptic connectors.
-
FAQs On The Revised EU GMP Annex 1: Volume 23/5/2025
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
MANUFACTURING LOGISTICS SOLUTIONS
-
Our 87,000 sq. ft. cGMP-certified drug product manufacturing facility, located in Baltimore, Maryland, offers aseptic fill/finish manufacturing of biologics and sterile injectables.
-
By combining deep scientific expertise with cutting-edge technology, we ensure the safety and effectiveness of each formulation through precise control of API release.
-
As a leading CDMO, we specialize in the development and manufacturing of diverse dosage forms for both clinical and commercial applications, driven by a culture of innovation and commitment to quality.
-
From start to finish, NovaPure components have been designed and manufactured using Quality by Design principles to mitigate risk for the patient.
-
The counterfeiting of pharmaceutical products is one of the most significant tasks facing pharmaceutical packaging companies. Discover consulting for your supply chain that ensures compliance and enhances traceability.